在急性SARS-CoV-2感染后的长期高凝血,内皮病和炎症
Andrea Boccatonda1, Elena Campello2, Chiara Simion2
1Internal Medicine, Bentivoglio Hospital, AUSL Bologna, Bentivoglio, Italy.
Expert review of hematology
|November 29, 2023
概括
冠状病毒疾病2019 (COVID-19) 幸存者面临心血管风险增加,原因是持续的炎症和内皮功能障碍. 微血块的形成有助于长期COVID症状和感染后的血栓事件.
科学领域:
- 心血管科学 心血管科学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 包括无症状病例在内的SARS-CoV-2感染增加了康复后心血管事件的风险.
- 长期COVID与持续的血栓和心血管并发症有关.
研究的目的:
- 审查COVID-19幸存者的血栓和心血管风险增加的证据.
- 在长期COVID中探索内皮功能障碍,炎症和凝血之间的病理生理联系.
主要方法:
- 系统地搜索聚焦高凝血性,内皮功能障碍和SARS-CoV-2感染后炎症的研究.
主要成果:
- 内皮功能障碍是COVID-19的一个关键机制,导致白细胞招募和炎症.
- 持续的免疫失调和高水平的促炎分子是长期COVID的特征.
- 活体中微血块的形成与持续的症状和心血管事件有关.
结论:
- 内皮功能障碍,免疫失调和微血块形成在COVID-19相关的心血管风险中至关重要.
- 了解这些机制对于管理长期COVID并发症至关重要.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
711
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
711
Extrinsic and Intrinsic Pathways of Hemostasis
7.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.8K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.8K
Inflammation
53.6K
Overview
53.6K
Disorders of Hemostasis
926
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
926


